145 related articles for article (PubMed ID: 9415228)
1. Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases.
Tomková H; Fujimoto W; Arata J
Br J Dermatol; 1997 Nov; 137(5):703-8. PubMed ID: 9415228
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer.
Delehedde M; Cho SH; Sarkiss M; Brisbay S; Davies M; El-Naggar AK; McDonnell TJ
Cancer; 1999 Apr; 85(7):1514-22. PubMed ID: 10193941
[TBL] [Abstract][Full Text] [Related]
3. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers.
Tomková H; Fujimoto W; Arata J
Eur J Dermatol; 1998 Jun; 8(4):256-60. PubMed ID: 9649682
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
5. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Bak expression in oral tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274
[TBL] [Abstract][Full Text] [Related]
8. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
9. Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.
Park GT; Seo EY; Lee KM; Lee DY; Yang JM
Br J Dermatol; 2006 Mar; 154(3):411-8. PubMed ID: 16445768
[TBL] [Abstract][Full Text] [Related]
10. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
Hussein MR; Al-Badaiwy ZH; Guirguis MN
J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family.
Krajewski S; Krajewska M; Reed JC
Cancer Res; 1996 Jun; 56(12):2849-55. PubMed ID: 8665525
[TBL] [Abstract][Full Text] [Related]
12. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
13. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: overexpression and redistribution in psoriasis and cutaneous carcinomas.
Moussali H; Bylaite M; Welss T; Abts HF; Ruzicka T; Walz M
Exp Dermatol; 2005 Jun; 14(6):420-8. PubMed ID: 15885077
[TBL] [Abstract][Full Text] [Related]
14. Filaggrin distribution in keratoacanthomas and squamous cell carcinoma.
Klein-Szanto AJ; Barr RJ; Reiners JJ; Mamrack MD
Arch Pathol Lab Med; 1984 Nov; 108(11):888-90. PubMed ID: 6385922
[TBL] [Abstract][Full Text] [Related]
15. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
Kanoh M; Amoh Y; Sato Y; Katsuoka K
Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
[TBL] [Abstract][Full Text] [Related]
16. Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin.
Morgan J; Oseroff AR; Cheney RT
Br J Dermatol; 2004 Oct; 151(4):846-56. PubMed ID: 15491426
[TBL] [Abstract][Full Text] [Related]
17. Expression of Bcl-2 family proteins in psoriasis.
Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2, bcl-x, bax and bak in renal parenchyma, oncocytomas and renal cell carcinomas.
Pammer J; Exner M; Regele H; Haitel A; Weninger W; Horvat R; Susani M
Pathol Res Pract; 1998; 194(12):837-45. PubMed ID: 9894249
[TBL] [Abstract][Full Text] [Related]
20. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
